MVP

Medical Developments International Limited

AU Healthcare Drug Manufacturers - Specialty & Generic

Latest week
10 Jul 2026
Close
0.405000
Fair value
0.599759
Next-week expectancy
Negative 38.53%
Sharemaestro

MVP Chart Pack

Medical Developments International Limited

Exchange
ASX
Latest week
10 Jul 2026
Close
0.405000
Fair value
0.599759
Next-week expectancy
Negative 38.53%
Generated
17 Jul 2026 02:08
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, MVP fell 22.12%, moving from 0.52 to 0.41. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -22.49 and has softened across the 12-week window. Market Dynamics is 0.42 on the latest week. Next-week expectancy is negative at 38.53% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
0.41
12-Week Change
-22.12%
Trend Signal
Inactive
Next-Week Expectancy
Negative 38.53%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-22.49
Market Dynamics
0.42

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
0.41
12-Week Change
-22.12%
Trend Signal
Inactive
Next-Week Expectancy
Negative 38.53%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-22.49
Market Dynamics
0.42

Over the latest 12 completed weeks ending 2026-07-10, MVP fell 22.12%, moving from 0.52 to 0.41. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -22.49 and has softened across the 12-week window. Market Dynamics is 0.42 on the latest week. Next-week expectancy is negative at 38.53% based on similar historical setup states.

Industry Peers

Australia equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
RGT Argent BioPharma Limited ASX 10 Jul 2026 0.04 0.11 0.04 0.07 105.71%
IVX Invion Limited ASX 10 Jul 2026 0.03 0.04 0.03 0.04 15.62%
LGP Little Green Pharma Ltd ASX 10 Jul 2026 0.07 0.07 0.07 0.07 4.48%
IDT IDT Australia Limited ASX 10 Jul 2026 0.03 0.03 0.03 0.03 3.23%
AFP AFT Pharmaceuticals Limited ASX 10 Jul 2026 3.04 3.30 3.04 3.13 2.96%
VLS Vita Life Sciences Limited ASX 10 Jul 2026 2.48 2.50 2.40 2.50 0.81%
BP8 BPH Global Ltd ASX 10 Jul 2026 0.00 0.00 0.00 0.00 0.00%
ECS ECS Botanics Holdings Ltd ASX 10 Jul 2026 0.01 0.01 0.00 0.01 0.00%
EPN Epsilon Healthcare Limited ASX 10 Jul 2026 0.02 0.02 0.02 0.02 0.00%
EXL Elixinol Wellness Limited ASX 10 Jul 2026 0.01 0.01 0.01 0.01 0.00%
PER PERCHERON FPO [PER] ASX 10 Jul 2026 0.00 0.00 0.00 0.00 0.00%
VIT Vitura Health Limited ASX 10 Jul 2026 0.03 0.03 0.03 0.03 0.00%
PKP PEAK FPO [PKP] ASX 10 Jul 2026 0.02 0.02 0.02 0.02 -5.56%
SNT Syntara Limited ASX 10 Jul 2026 0.03 0.03 0.02 0.02 -8.00%
CAN Cann Group Limited ASX 10 Jul 2026 0.01 0.01 0.00 0.00 -10.00%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.